We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
AQUIPTA (Allergan Australia Pty Ltd)
Product name
AQUIPTA
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
211 (255 working days)
Active ingredients
atogepant
Registration type
NCE/NBE
Indication
AQUIPTA is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month